Insights
Newsletters
2026 Mid-Year Technology and Life Sciences PIPE and RDO Report
Wilson Sonsini is pleased to present the 2026 Mid-Year Technology and Life Sciences PIPE and RDO Report, analyzing 103 private investments in public equity (PIPEs) and registered direct offerings (RDOs) by U.S.-based technology and life sciences companies between January 1 and June 30, 2026.
Newsletters
2026 Mid-Year Technology and Life Sciences IPO Report
Wilson Sonsini's 2026 Mid-Year Technology and Life Sciences IPO Report presents in-depth analysis related to 37 initial public offerings (IPOs) with deal values exceeding $75 million or direct listings completed by U.S.-based technology and life sciences companies between January 1 and June 30, 2026.
Newsletters
European Antitrust Bimonthly Bulletin – July/August 2026
The firm is pleased to distribute the European Antitrust Bimonthly Bulletin, which distills the major antitrust developments in Europe over the past two months into concise and actionable takeaways. Companies operating in, or transacting with, Europe should take note of this quarter's developments in merger enforcement, digital markets regulation, and AI-related antitrust scrutiny.
All Results
Alerts
10.23.26
Cybersecurity Vulnerabilities and Security Updates: Why Hours Matter, What Defense Tech and Dual Use Companies Should Do Now
On October 21, 2026, the PHP project patched two critical remote-code-execution vulnerabilities, together called php2shell, that affect nearly every system running PHP to serve web traffic, including sites built on WordPress, Drupal, and Magento, as well as many custom portals. Technical details of the vulnerability leaked before the fix was released, so the window between disclosure and active exploitation was short. Patching is available and inexpensive. The cost of waiting for exposed companies is not only a possible breach, but also the legal and contractual exposure that the delay itself creates—especially for heavily regulated entities, such as U.S. government contractors that handle Controlled Unclassified Information (CUI).
Client Highlights
10.23.26
Firm Advises PepStar Therapeutics on Patent Matters Related to Acquisition of Inflammation Drug Program by Gilead Sciences
On October 22, 2026, Gilead Sciences, a biopharmaceutical company pursuing breakthroughs in medicine, announced that it has entered into a definitive agreement to acquire an oral IL-23R inhibitor program, including lead asset HCXT-2001, from PepStar Therapeutics Limited, a privately held, clinical-stage biotechnology company, for $1.275 billion in upfront cash consideration, subject to customary adjustments. The transaction is expected to close later in 2026. Wilson Sonsini Goodrich & Rosati is advising PepStar on patent matters related to the transaction.
Client Highlights
10.23.26
Wilson Sonsini Advises Prana Therapies on IP Matters Related to Acquisition by Bolt Biotherapeutics
On October 23, 2026, Bolt Biotherapeutics, a clinical-stage biotechnology company, announced the acquisition of Prana Therapies, a clinical-stage biotechnology company pioneering next-generation half-life-extended multispecific antibodies designed to deliver best-in-disease therapies. Following the acquisition, Bolt Biotherapeutics will focus on advancing Prana’s pipeline of half-life-extended multispecific antibodies generated from its proprietary INSPIRE platform, led by PRA-216, a novel IL-4Rα/TSLP bispecific antibody currently in Phase 2 development in asthma, chronic obstructive pulmonary disease (COPD), and atopic dermatitis, with a Phase 2 study in eosinophilic esophagitis (EoE) planned. Wilson Sonsini Goodrich & Rosati advised Prana Therapies on the intellectual property matters related to the transaction.
Client Highlights
10.22.26
Wilson Sonsini Advises Otter.ai on $320 Million Growth Investment
On October 20, 2026, Otter.ai, the company behind the leading AI notetaker and conversational knowledge platform, announced $320 million in growth financing from General Catalyst's Customer Value Fund. Wilson Sonsini Goodrich & Rosati advised Otter.ai on the transaction.
Alerts
10.21.26
California OHCA Finalizes AB 1415 Regulations: Key Takeaways for Private Equity, Venture Capital, and MSO Transactions
California’s Office of Health Care Affordability (OHCA) has finalized regulations implementing Assembly Bill 1415 (AB 1415), providing additional guidance regarding the application of California’s healthcare transaction notice requirements to private equity groups, hedge funds, management services organizations (MSOs), and other entities involved in healthcare transactions. The final regulations become effective November 2, 2026.
Alerts
10.21.26
Subscriptions in the Spotlight: UK CMA Prepares for New Consumer Protection Regime
On October 19, 2026, the UK government published draft guidance on the country’s new consumer subscription contracts regime. This regime, which is set to come into force on January 1, 2027, will introduce new requirements for traders to provide transparent information to consumers, deliver renewal reminders, provide simple cancellation mechanisms, and respect cooling-off rights. The government also previously announced that it will consult on whether certain pricing practices, including “fake” discounts, should be added to the UK’s list of banned commercial practices, with the aim of facilitating effective enforcement action.
Client Highlights
10.21.26
Wilson Sonsini Advises ElevenLabs on $300 Million Employee Tender Offer
On September 30, 2026, ElevenLabs, a voice technology research company, announced the closing of a $300 million employee tender offer that values the company at $22 billion, doubling its valuation at its Series D financing in February 2026. The tender offer was led by Wellington and T. Rowe Price, with participation from new investors BDT & MSD, EQT, GIC, Goldman Sachs, OTPP, and Sapphire Ventures, as well as existing investors including Alkeon, Andreessen Horowitz, D.E. Shaw, DISRUPTIVE, Evantic, ICONIQ, and Lightspeed. Wilson Sonsini Goodrich & Rosati advised Elevenlabs on the transaction.
Client Highlights
10.21.26
Wilson Sonsini Advises Tenstorrent on $1.5 Billion Series E Financing
On October 19, 2026, Tenstorrent, an artificial intelligence (AI) computing company, announced it has closed $1.5 billion in Series E funding at a $6.2 billion post-money valuation. The round was led by Trace Capital and Innovation X, with participation from new and existing investors including Agostinelli Group, ARK Invest, Brett Barna, Cadence Ventures, Eclipse, Fidelity Management & Research Company, Maverick Silicon, Morgan Stanley, Protagonist, Sandisk, T. Rowe Price, Tether Investments, Troluce Capital, Virtu Financial, and XTX Markets. Wilson Sonsini Goodrich & Rosati represented Tenstorrent on the transaction.
News Articles
10.21.26
Wilson Sonsini Recognized in the 2026 Law360 Pulse Leaderboard
Wilson Sonsini has been recognized in the 2026 Law360 Pulse Leaderboard, which evaluates law firms across three pillars: prestige, platform strength, and practice footprint. Now in its sixth year, the annual ranking reflects the evolving factors that define success in an increasingly competitive legal market.
Blog Posts
10.20.26
Corp Fin Issues New and Revised CFIs on Use of Form S-8, Rule 701, and Form 4 Deadlines
The SEC’s Division of Corporation Finance recently published six new and two revised Corporation Finance Interpretations (CFIs) addressing the registration of stock underlying equity compensation awards and benefit plans. Collectively, the CFIs ease several longstanding staff positions on the timing of Form S-8 registration for restricted stock and restricted stock units, the treatment of awards assumed from acquired companies, and awards granted prior to an initial public offering.
Client Highlights
10.20.26
Firm Advises Clearway on Agreements with PacifiCorp for Additional 210 MW of Battery Energy Storage in Utah
On October 9, 2026, Clearway Energy Group (Clearway) announced an additional 210 megawatts (MW) of battery energy storage to its Honeycomb Energy Center fleet in southern Utah, supported by long-term contracts with PacifiCorp. The new storage capacity will help balance supply and demand on Utah’s electrical grid. Wilson Sonsini Goodrich & Rosati advised Clearway on the transaction with PacifiCorp.